Peter Bisgaard is a partner in Novo Ventures Novo A/S and has been with the firm since 2001. Prior to joining Novo A/S, Peter directed strategy development, mergers, acquisitions and alliances at McKinsey & Co. as a general consultant and as a specialist within the Scandinavian Corporate Finance and Strategy Group. Mr. Bisgaard is also a member of the boards of directors of Altheos, Inc., Asante Solutions, Inc., Light Sciences Oncology and Otonomy, Inc. He previously served on the boards of HemoFocus ApS, NatImmune A/S and Neurokey A/S. He is the co-author of “Growth by Mergers & Acquisitions” published by Børsens Forlag, 2004. Mr. Bisgaard earned an MSc from the Technical University of Denmark and was at the same time awarded a post graduate degree in Mathematical Modeling in Economics by the European Consortium for Mathematics.